BlackRock Health Sciences Trust (NYSE:BME) focuses on capital appreciation by investing in a dynamic portfolio of healthcare and sciences companies. With investments ranging across pharmaceuticals, biotechnology, and healthcare equipment and services, it aims to provide investors with exposure to the growth potential of the health sciences sector. The trust's projects involve actively managing investments in public health sciences companies, with the objective of achieving long-term capital growth. Through its strategic allocations, BlackRock Health Sciences Trust seeks to capitalize on the evolving landscape of the healthcare industry, including technological advancements and demographic shifts affecting health services demand.